FDA posts a final report from an agency-contracted sampling of talc-containing cosmetic products for the presence of asbestos.
Federal Register notice: FDA reopens until 5/5 the comment period for a 11/7/2019 notice on Best Practices in Drug and Biological Product Postmarket S...
FDA issues a new draft guidance on Type 2 Diabetes Mellitus: Evaluating the Safety of New Drugs for Improving Glycemic Control that proposes to remove...
FDA accepts for review a Mylan/Biocon BLA for MYL-1402O, a biosimilar candidate referencing Genentechs Avastin (bevacizumab).
FDA announces a 4/3 public meeting entitled U.S. Food and Drug Administration and Health Canada Joint Regional Consultation on the International Counc...
FDA approves Boehringer Ingelheim Pharmaceuticals Ofev (nintedanib) oral capsules to treat patients with chronic fibrosing interstitial lung diseases ...
FDA Review posts the Federal Register notices for the week ending 3/6/2020.
Federal Register notice: FDA makes available a draft guidance entitled Inclusion of Older Adults in Cancer Clinical Trials.